By Sahil Pandey March 10 (Reuters) - Medical device maker Medtronic said on Tuesday it would buy U.S.-based Scientia Vascular ...

Medtronic has bought a stroke-treating device firm for $550 million as the Fridley-operated medtech company executes its growth strategy of mergers and acquisitions. Scientia Vascular launched the ...

When it comes to medical devices, some of the most exciting ones, to me, are robotic surgical systems. Intuitive Surgical has ...

Medtronic plc (NYSE:MDT) is included among the 13 Undervalued Dividend Aristocrats to Buy Now. Medtronic plc (NYSE:MDT) ...

Sleep Number's new CEO is planning to make the bed manufacturer profitable with a smaller product lineup. Also, Medtronic has ...

Medtronic's diabetes business MiniMed shares opened 4.8% below their offer price in Nasdaq debut ​on Friday, valuing it at $5 ...

The stock is especially attractive to income seekers.

MiniMed, Medtronic’s diabetes tech spinoff, made its debut on the public markets Friday. The company started trading on the ...

In early March 2026, Medtronic reported stronger-than-expected Q3 2026 results with 6% year-over-year organic revenue growth and affirmed a US$0.71 quarterly dividend per share, extending its 48-year ...

Medtronic announced today that it has entered into a definitive agreement to acquire Scientia Vascular for $550 million.

Medtronic today announced its entry into a definitive agreement to acquire Scientia Vascular, a company with critical, innovative technology across the neurovascular portfolio. The acquisition is ...

Medtronic today shared new, long-term data demonstrating the clinical benefit of its Symplicity Spyral renal denervation (RDN) system.